“Safety Profile of 5% Albumin Versus Fresh Frozen Plasma in Therapeutic Plasma Exchange for Guillain-Barré Syndrome”. 2026. The Planet 9 (2): 9-13. https://doi.org/10.5281/zenodo.19497028.